Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
89.14 EUR | +1.10% | +2.64% | -0.76% |
09:04am | Sanofi: positive phase III data in IPT | CF |
07:45am | Sanofi Reports Positive Results from Phase 3 Trial of Rilzabrutinib for Immune Thrombocytopenia | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.69% | 117B | |
+25.46% | 659B | |
+25.38% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.13% | 215B | |
+2.93% | 210B | |
-7.65% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- Sanofi : Plans $476 Million Annual Investments In New mRNA Vaccine Center